Nigel J Temperton (Nigel Temperton)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 43

Top Venues

Nature communications

Vaccines

Viruses

Pathogens (Basel, Switzerland)

University of Kent

London School of Hygiene and Tropical Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Kent Oct 01 2009

United Kingdom

Senior Lecturer :: Medway School of Pharmacy

Education History

London School of Hygiene and Tropical Medicine

United Kingdom

PHD

London School of Hygiene and Tropical Medicine

United Kingdom

MSC

Publications

Chang Liu, Raksha Das, Aiste Dijokaite-Guraliuc, Daming Zhou, Alexander J Mentzer, Piyada Supasa, Muneeswaran Selvaraj, Helen M E Duyvesteyn, Thomas G Ritter, Nigel J Temperton, Paul Klenerman, Susanna J Dunachie, Neil G Paterson, Mark A Williams, David R Hall, Elizabeth E Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I Stuart, Gavin R Screaton
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection. Nature communications 15 (1) (2024)
Chang Liu, Raksha Das, Aiste Dijokaite-Guraliuc, Daming Zhou, Alexander J Mentzer, Piyada Supasa, Muneeswaran Selvaraj, Helen M E Duyvesteyn, Thomas G Ritter, Nigel J Temperton, Paul Klenerman, Susanna J Dunachie, Neil G Paterson, Mark A Williams, David R Hall, Elizabeth E Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I Stuart, Gavin R Screaton
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection. Nature communications 15 (1) (2024)
Daming Zhou, Piyada Supasa, Chang Liu, Aiste Dijokaite-Guraliuc, Helen M E Duyvesteyn, Muneeswaran Selvaraj, Alexander J Mentzer, Raksha Das, Wanwisa Dejnirattisai, Nigel J Temperton, Paul Klenerman, Susanna J Dunachie, Elizabeth E Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I Stuart, Gavin R Screaton
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86. Nature communications 15 (1) (2024)
Sneha Vishwanath, George William Carnell, Martina Billmeier, Luis Ohlendorf, Patrick Neckermann, Benedikt Asbach, Charlotte L George, Maria Suau Sans, Andrew Chan, Joey Olivier, Angalee Nadesalingam, Sebastian Einhauser, Nigel J Temperton, Diego Cantoni, Joe Grove, Ingo Jordan, Volker Sandig, Paul Tonks, Johannes Geiger, Christian Dohmen, Verena Mummert, Anne Rosalind Samuel, Christian Plank, Rebecca Kinsley, Ralf Wagner, Jonathan Luke Heeney
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants. NPJ vaccines 9 (1) (2024)
Chang Liu, Raksha Das, Aiste Dijokaite-Guraliuc, Daming Zhou, Alexander J Mentzer, Piyada Supasa, Muneeswaran Selvaraj, Helen M E Duyvesteyn, Thomas G Ritter, Nigel J Temperton, Paul Klenerman, Susanna J Dunachie, Neil G Paterson, Mark A Williams, David R Hall, Elizabeth E Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I Stuart, Gavin R Screaton
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection. Nature communications 15 (1) (2024)
Chang Liu, Raksha Das, Aiste Dijokaite-Guraliuc, Daming Zhou, Alexander J Mentzer, Piyada Supasa, Muneeswaran Selvaraj, Helen M E Duyvesteyn, Thomas G Ritter, Nigel J Temperton, Paul Klenerman, Susanna J Dunachie, Neil G Paterson, Mark A Williams, David R Hall, Elizabeth E Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I Stuart, Gavin R Screaton
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection. Nature communications 15 (1) (2024)
Daming Zhou, Piyada Supasa, Chang Liu, Aiste Dijokaite-Guraliuc, Helen M E Duyvesteyn, Muneeswaran Selvaraj, Alexander J Mentzer, Raksha Das, Wanwisa Dejnirattisai, Nigel J Temperton, Paul Klenerman, Susanna J Dunachie, Elizabeth E Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I Stuart, Gavin R Screaton
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86. Nature communications 15 (1) (2024)
Fern Jenkins, Tobias Mapulanga, Gauri Thapa, Kelly A S da Costa, Nigel J Temperton
Conference Report: LPMHealthcare Emerging Viruses 2023 (EVOX23): Pandemics-Learning from the Past and Present to Prepare for the Future. Pathogens (Basel, Switzerland) 13 (8) (2024)
Daming Zhou, Piyada Supasa, Chang Liu, Aiste Dijokaite-Guraliuc, Helen M E Duyvesteyn, Muneeswaran Selvaraj, Alexander J Mentzer, Raksha Das, Wanwisa Dejnirattisai, Nigel J Temperton, Paul Klenerman, Susanna J Dunachie, Elizabeth E Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I Stuart, Gavin R Screaton
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86. Nature communications 15 (1) (2024)
Daming Zhou, Piyada Supasa, Chang Liu, Aiste Dijokaite-Guraliuc, Helen M E Duyvesteyn, Muneeswaran Selvaraj, Alexander J Mentzer, Raksha Das, Wanwisa Dejnirattisai, Nigel J Temperton, Paul Klenerman, Susanna J Dunachie, Elizabeth E Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I Stuart, Gavin R Screaton
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86. Nature communications 15 (1) (2024)
Sneha Vishwanath, George William Carnell, Matteo Ferrari, Benedikt Asbach, Martina Billmeier, Charlotte L George, Maria Suau Sans, Angalee Nadesalingam, Chloe Qingzhou Huang, Minna Paloniemi, Hazel Stewart, Andrew Chan, David Arthur Wells, Patrick Neckermann, David Peterhoff, Sebastian Einhauser, Diego Cantoni, Martin Mayora Neto, Ingo Jordan, Volker Sandig, Paul Tonks, Nigel J Temperton, Simon Frost, Katharina Sohr, Maria Teresa Lluesma Ballesteros, Farzad Arbabi, Johannes Geiger, Christian Dohmen, Christian Plank, Rebecca Kinsley, Ralf Wagner, Jonathan Luke Heeney
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses. Nature biomedical engineering (2023)
Nazar Beirag, Praveen M Varghese, Martin Mayora Neto, Ahmad Al Aiyan, Haseeb Ahmad Khan, Moneeb Qablan, Mohamed H Shamji, Robert B Sim, Nigel J Temperton, Uday Kishore
Complement Activation-Independent Attenuation of SARS-CoV-2 Infection by C1q and C4b-Binding Protein. Viruses 15 (6) (2023)
Nazar Beirag, Praveen M Varghese, Martin Mayora Neto, Ahmad Al Aiyan, Haseeb Ahmad Khan, Moneeb Qablan, Mohamed H Shamji, Robert B Sim, Nigel J Temperton, Uday Kishore
Complement Activation-Independent Attenuation of SARS-CoV-2 Infection by C1q and C4b-Binding Protein. Viruses 15 (6) (2023)
Joanne Marie M Del Rosario, Kelly A S da Costa, Nigel J Temperton
Pseudotyped Viruses for Influenza. Advances in experimental medicine and biology 1407 (2023)
Nazar Beirag, Praveen M Varghese, Martin Mayora Neto, Ahmad Al Aiyan, Haseeb Ahmad Khan, Moneeb Qablan, Mohamed H Shamji, Robert B Sim, Nigel J Temperton, Uday Kishore
Complement Activation-Independent Attenuation of SARS-CoV-2 Infection by C1q and C4b-Binding Protein. Viruses 15 (6) (2023)
Martin Mayora Neto, Edward Wright, Nigel J Temperton, Peter Soema, Rimko Ten Have, Ivo Ploemen, Simon D Scott
Application and comparison of lyophilisation protocols to enhance stable long-term storage of filovirus pseudotypes for use in antibody neutralisation tests. Journal of applied microbiology 134 (2) (2023)
Kelly A S da Costa, Joanne Marie M Del Rosario, Matteo Ferrari, Sneha Vishwanath, Benedikt Asbach, Rebecca Kinsley, Ralf Wagner, Jonathan L Heeney, George William Carnell, Nigel J Temperton
Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design. Vaccines 10 (9) (2022)
Martin Mayora Neto, Edward Wright, Nigel J Temperton, Peter Soema, Rimko Ten Have, Ivo Ploemen, Simon D Scott
Application and comparison of lyophilisation protocols to enhance stable long-term storage of filovirus pseudotypes for use in antibody neutralisation tests. Journal of applied microbiology (2022)
Gábor Kemenesi, Gábor Endre Tóth, Martin Mayora Neto, Simon D Scott, Nigel J Temperton, Edward Wright, Elke Mühlberger, Adam J Hume, Ellen L Suder, Brigitta Zana, Sándor András Boldogh, Tamás Görföl, Péter Estók, Tamara Szentiványi, Zsófia Lanszki, Balázs A Somogyi, Ágnes Nagy, Csaba I Pereszlényi, Gábor Dudás, Fanni Földes, Kornélia Kurucz, Mónika Madai, Safia Zeghbib, Piet Maes, Bert Vanmechelen, Ferenc Jakab
Author Correction: Isolation of infectious Lloviu virus from Schreiber's bats in Hungary. Nature communications 13 (1) (2022)
Diego Cantoni, Gabriel Siracusano, Martin Mayora Neto, Claudia Pastori, Tobia Fantoni, Spyros Lytras, Cecilia Di Genova, Joseph Hughes, null On Behalf Of The Ambulatorio Medico San Luca Villanuova Group, Lopalco Lucia, Nigel J Temperton
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms. Vaccines 11 (1) (2022)
Diego Cantoni, Gabriel Siracusano, Martin Mayora Neto, Claudia Pastori, Tobia Fantoni, Spyros Lytras, Cecilia Di Genova, Joseph Hughes, null On Behalf Of The Ambulatorio Medico San Luca Villanuova Group, Lopalco Lucia, Nigel J Temperton
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms. Vaccines 11 (1) (2022)
Gábor Kemenesi, Gábor Endre Tóth, Martin Mayora Neto, Simon D Scott, Nigel J Temperton, Edward Wright, Elke Mühlberger, Adam J Hume, Ellen L Suder, Brigitta Zana, Sándor András Boldogh, Tamás Görföl, Péter Estók, Tamara Szentiványi, Zsófia Lanszki, Balázs A Somogyi, Ágnes Nagy, Csaba I Pereszlényi, Gábor Dudás, Fanni Földes, Kornélia Kurucz, Mónika Madai, Safia Zeghbib, Piet Maes, Bert Vanmechelen, Ferenc Jakab
Isolation of infectious Lloviu virus from Schreiber's bats in Hungary. Nature communications 13 (1) (2022)
Diego Cantoni, Martin Mayora Neto, Nazia Thakur, Ahmed M E Elrefaey, Joseph Newman, Sneha Vishwanath, Angalee Nadesalingam, Andrew Chan, Peter Smith, Javier Castillo-Olivares, Helen Baxendale, Bryan Charleston, Jonathan Luke Heeney, Dalan Bailey, Nigel J Temperton
Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients. Communications biology 5 (1) (2022)
Diego Cantoni, Gabriel Siracusano, Martin Mayora Neto, Claudia Pastori, Tobia Fantoni, Spyros Lytras, Cecilia Di Genova, Joseph Hughes, null On Behalf Of The Ambulatorio Medico San Luca Villanuova Group, Lopalco Lucia, Nigel J Temperton
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms. Vaccines 11 (1) (2022)
David K Lau, Maria Aresu, Timothy Planche, Amina Tran, Retchel Lazaro-Alcausi, Julie Duncan, Shannon Kidd, Susan Cromarty, Ruwaida Begum, Isma Rana, Su Li, Ali Abdulnabi Mohamed, Irene Monahan, David J Clark, Nicholas Eckersley, Henry M Staines, Elisabetta Groppelli, Sanjeev Krishna, Martin Mayora-Neto, Nigel J Temperton, Charlotte Fribbens, David Watkins, Naureen Starling, Ian Chau, David Cunningham, Sheela Rao
SARS-CoV-2 Vaccine Immunogenicity in Patients with Gastrointestinal Cancer Receiving Systemic Anti-Cancer Therapy. The oncologist (2022)
Diego Cantoni, Gabriel Siracusano, Martin Mayora Neto, Claudia Pastori, Tobia Fantoni, Spyros Lytras, Cecilia Di Genova, Joseph Hughes, null On Behalf Of The Ambulatorio Medico San Luca Villanuova Group, Lopalco Lucia, Nigel J Temperton
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms. Vaccines 11 (1) (2022)
Leiping Zeng, Yanxia Liu, Xammy Huu Nguyenla, Timothy R Abbott, Mengting Han, Yanyu Zhu, Augustine Chemparathy, Xueqiu Lin, Xinyi Chen, Haifeng Wang, Draven A Rane, Jordan M Spatz, Saket Jain, Arjun Rustagi, Benjamin A Pinsky, Adrianna E Zepeda, Anastasia P Kadina, John A Walker, Kevin Holden, Nigel J Temperton, Jennifer R Cochran, Annelise E Barron, Michael D Connolly, Catherine A Blish, David B Lewis, Sarah A Stanley, Marie F La Russa, Lei S Qi
Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro. Nature communications 13 (1) (2022)
George William Carnell, Claudia Maria Trombetta, Francesca Ferrara, Emanuele Montomoli, Nigel J Temperton
Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines. Vaccines 9 (2) (2021)
Joanne Marie M Del Rosario, Kelly A S da Costa, Benedikt Asbach, Francesca Ferrara, Matteo Ferrari, David A Wells, Gurdip Singh Mann, Veronica O Ameh, Claude T Sabeta, Ashley C Banyard, Rebecca Kinsley, Simon D Scott, Ralf Wagner, Jonathan L Heeney, George William Carnell, Nigel J Temperton
Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection. Vaccines 9 (7) (2021)
Catherine J Reynolds, Leo Swadling, Joseph M Gibbons, Corinna Pade, Melanie Peta Jensen, Mariana O Diniz, Nathalie M Schmidt, David K Butler, Oliver E Amin, Sasha N L Bailey, Sam M Murray, Franziska P Pieper, Stephen Taylor, Jessica Jones, Meleri Jones, Wing-Yiu Jason Lee, Joshua Rosenheim, Aneesh Chandran, George Joy, Cecilia Di Genova, Nigel J Temperton, Jonathan Lambourne, Teresa Cutino-Moguel, Mervyn Andiapen, Marianna Fontana, Angelique Smit, Amanda Semper, Benjamin O'Brien, Benjamin M Chain, Tim J G Brooks, Charlotte H Manisty, Thomas A Treibel, James C Moon, null null, Mahdad Noursadeghi, null null, Daniel M Altmann, Mala K Maini, Áine McKnight, Rosemary J Boyton
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection. Science immunology 5 (54) (2021)
Alexander Thomas Sampson, Jonathan Heeney, Diego Cantoni, Matteo Ferrari, Maria Suau Sans, Charlotte George, Cecilia Di Genova, Martin Mayora Neto, Sebastian Einhauser, Benedikt Asbach, Ralf Wagner, Helen Baxendale, Nigel J Temperton, George William Carnell
Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses. Viruses 13 (8) (2021)
Diego Cantoni, Martin Mayora-Neto, Nigel J Temperton
The role of pseudotype neutralization assays in understanding SARS CoV-2. Oxford open immunology 2 (1) (2021)
Steven A Kemp, Dami Aderonke Collier, Rawlings P Datir, Isabella A T M Ferreira, Salma Gayed, Aminu S Jahun, Myra Hosmillo, Chloe Rees-Spear, Petra Mlcochova, Ines Ushiro Lumb, David J Roberts, Anita Chandra, Nigel J Temperton, null null, null null, Katherine Sharrocks, Elizabeth Blane, Yorgo Modis, Kendra E Leigh, John A G Briggs, Marit J van Gils, Kenneth G C Smith, John R Bradley, Chris Smith, Rainer Doffinger, Lourdes Ceron-Gutierrez, Gabriela Barcenas-Morales, David D Pollock, Richard A Goldstein, Anna Smielewska, Jordan Peter Skittrall, Theodore Gouliouris, Ian G Goodfellow, Effrossyni Gkrania-Klotsas, Christopher J R Illingworth, Laura E McCoy, Ravindra Kumar Gupta
SARS-CoV-2 evolution during treatment of chronic infection. Nature 592 (7853) (2021)
Fabian Z X Lean, Mart M Lamers, Samuel P Smith, Rebecca Shipley, Debby Schipper, Nigel J Temperton, Bart L Haagmans, Ashley C Banyard, Kevin R Bewley, Miles W Carroll, Sharon M Brookes, Ian Brown, Alejandro Nuñez
Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens. Scientific reports 10 (1) (2020)
Inesa Hyseni, Eleonora Molesti, Linda Benincasa, Pietro Piu, Elisa Casa, Nigel J Temperton, Alessandro Manenti, Emanuele Montomoli
Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays. Viruses 12 (9) (2020)
Jeffrey Seow, Carl Graham, Blair Merrick, Sam Acors, Suzanne Pickering, Kathryn J A Steel, Oliver Hemmings, Aoife O'Byrne, Neophytos Kouphou, Rui Pedro Galao, Gilberto Betancor, Harry D Wilson, Adrian W Signell, Helena Winstone, Claire Kerridge, Isabella Huettner, Jose M Jimenez-Guardeño, Maria Jose Lista, Nigel J Temperton, Luke Blagdon Snell, Karen Bisnauthsing, Amelia Moore, Adrian Green, Lauren Martinez, Brielle Stokes, Johanna Honey, Alba Izquierdo-Barras, Gill Arbane, Amita Patel, Mark Kia Ik Tan, Lorcan O'Connell, Geraldine O'Hara, Eithne MacMahon, Sam Douthwaite, Gaia Nebbia, Rahul Batra, Rocio Martinez-Nunez, Manu Shankar-Hari, Jonathan D Edgeworth, Stuart J D Neil, Michael H Malim, Katie J Doores
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nature microbiology 5 (12) (2020)
Rebecca Kinsley, Stéphane Pronost, Manuelle De Bock, Nigel J Temperton, Janet M Daly, Romain Paillot, Simon D Scott
Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection. Vaccines 8 (3) (2020)
Walter Ramage, Tiziano Gaiotto, Christina Ball, Paul Risley, George William Carnell, Nigel J Temperton, Chung Y Cheung, Othmar G Engelhardt, Simon E Hufton
Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin. Antibodies (Basel, Switzerland) 8 (1) (2019)
Naif Khalaf Alharbi, Ibrahim Qasim, Abdulrahman Almasoud, Haya A Aljami, Mohamed W Alenazi, Ali Alhafufi, Omar S Aldibasi, Anwar M Hashem, Samy Kasem, Raed Albrahim, Musaad Aldubaib, Ali Almansour, Nigel J Temperton, Alexandra Kupke, Stephan Becker, Ali Abu-Obaidah, Ali Alkarar, In-Kyu Yoon, Esam Azhar, Teresa Lambe, Faisal Bayoumi, Ali Aldowerij, Osman H Ibrahim, Sarah C Gilbert, Hanan H Balkhy
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels. Scientific reports 9 (1) (2019)
Michela Mazzon, Ana Maria Ortega-Prieto, Douglas Imrie, Christin Luft, Lena Hess, Stephanie Czieso, Joe Grove, Jessica Katy Skelton, Laura Farleigh, Joachim J Bugert, Edward Wright, Nigel J Temperton, Richard Angell, Sally Oxenford, Michael Jacobs, Robin Ketteler, Marcus Dorner, Mark Marsh
Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry. Viruses 11 (2) (2019)
Francesca Ferrara, Nigel J Temperton
Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis. Methods and protocols 1 (1) (2018)
Craig P Thompson, Paul S Wikramaratna, Adam A Walters, Uri Obolski, Matthew Edmans, Duncan S Palmer, Kreepa Kooblall, George W Carnell, Daniel O' Connor, Thomas A Bowden, Oliver G Pybus, Andrew J Pollard, Nigel J Temperton, Teresa Lambe, Sarah C Gilbert, Sunetra Gupta
A naturally protective epitope of limited variability as an influenza vaccine target. Nature communications 9 (1) (2018)
Francesca Ferrara, Eleonora Molesti, Simon Scott, Giovanni Cattoli, Nigel J Temperton
The Use of Hyperimmune Chicken Reference Sera Is Not Appropriate for the Validation of Influenza Pseudotype Neutralization Assays. Pathogens (Basel, Switzerland) 6 (4) (2017)
Eleonora Molesti, Edward Wright, Calogero Terregino, Rafat Rahman, Giovanni Cattoli, Nigel J Temperton
Multiplex evaluation of influenza neutralizing antibodies with potential applicability to in-field serological studies. Journal of immunology research 2014 (2014)
Eleonora Molesti, Francesca Ferrara, Giulia Lapini, Emanuele Montomoli, Nigel J Temperton
Discordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals. BioMed research international 2014 (2014)

Nigel J Temperton.css-eqlu8i{font-size:small;padding-left:4px;} (Nigel Temperton)

Publication Activity (10 Years)

Top Topics

Top Venues

Nigel J Temperton (Nigel Temperton)